Katrijn Coen

Title: Katrijn Coen: Innovator in Alzheimer's Disease Research

Introduction

Katrijn Coen is a notable inventor based in Westerlo, Belgium. She has made significant contributions to the field of neuroscience, particularly in the context of Alzheimer's disease. Her innovative work focuses on understanding and addressing disorders of the peripheral and central nervous systems.

Latest Patents

Katrijn Coen holds a patent for her invention titled "Screening methods for compounds that modulate ARF-6 mediated endosomal redistribution." This invention is particularly relevant to Alzheimer's disease, as it identifies ARF6 and its effector proteins as new targets for treatment. The patent outlines methods for screening compounds that can reduce amyloid beta peptide formation in mammalian cells by influencing ARF6-mediated endosomal sorting. She has 1 patent to her name.

Career Highlights

Throughout her career, Katrijn has worked with various esteemed organizations. Notably, she has been associated with Vib Vzw and Katholieke Universiteit Leuven, also known as KU Leuven R&D. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Katrijn Coen has collaborated with several prominent researchers in her field. Among her notable coworkers are Wim Annaert and Ragna Sannerud. These collaborations have enriched her research and expanded the impact of her work.

Conclusion

Katrijn Coen is a pioneering inventor whose work is making strides in the fight against Alzheimer's disease. Her innovative approaches and collaborations are paving the way for new treatments and understanding of this complex disorder.